Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Angela Marini"'
Esta pesquisa visa evidenciar as semelhanças existentes entre a proposta de Giambattista Vico sobre o começo das civilizações gentílicas e as argumentações rabínicas relativas ao episódio do Dilúvio Universal, narrado em Gênesis 6 e consid
Autor:
Medhi Wangpaichitr, John S. Bomalaski, Frederick L. Moffat, Chunjing Wu, Niramol Savaraj, W. Sisson, Macus Tien Kuo, Angela Marini, Min You, George W. Elgart, Lynn G. Feun, G. Walker, Achim A. Jungbluth, S. E. Rodgers
Publikováno v:
British Journal of Cancer
Background: Arginine-depleting therapy with pegylated arginine deiminase (ADI-PEG20) was reported to have activity in advanced melanoma in early phase I–II trial, and clinical trials are currently underway in other cancers. However, the optimal pat
Autor:
Maria Angela Marini Esposito
Publikováno v:
Biblioteca Digital de Teses e Dissertações da USP
Universidade de São Paulo (USP)
instacron:USP
Universidade de São Paulo (USP)
instacron:USP
Esta pesquisa visa evidenciar as semelhanças existentes entre a proposta de Giambattista Vico sobre o começo das civilizações gentílicas e as argumentações rabínicas relativas ao episódio do Dilúvio Universal, narrado em Gênesis 6 e consid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74b7dfbb34c25b71847a17c0527f9a77
https://doi.org/10.11606/d.8.2007.tde-10082007-150045
https://doi.org/10.11606/d.8.2007.tde-10082007-150045
Autor:
Cristina Herrera, Carlos Robles, Niramol Savaraj, Deborah Heros, Howard J. Landy, Angela Marini, Arnold M. Markoe, Lynn G. Feun
Publikováno v:
Journal of Neuro-Oncology. 82:177-181
CPT-11 is a potent inhibitor of topoisomerase I and has shown antitumor activity in brain xenografts and in clinical trials in recurrent/progressive malignant glioma. VM-26 and VP-16 are topoisomerase II inhibitors and have also shown activity in pha
Autor:
Manuel Modiano, Patricia M. Plezia, Susan MacDonald, Angela Marini, Niramol Savaraj, Bijan Almassian, Jessica Fischer, Lynn G. Feun, King C. Lee, John Mao, Elizabeth Colacino
Publikováno v:
Cancer Chemotherapy and Pharmacology. 50:223-229
Purpose. To perform a phase I and pharmacokinetics study of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) a new ribonucleotide reductase inhibitor using a single intravenous (2-h) schedule every 4 weeks. 3-AP was given at a starting dose
Publikováno v:
Cancer. 88:584-588
BACKGROUND The aim of the current trial was to assess the efficacy and toxicity of weekly intravenous vinorelbine tartrate with daily oral tamoxifen in the treatment of patients with advanced or metastatic malignant melanoma. METHODS Thirty-one patie
Autor:
Maria Angela Marini Esposito
Publikováno v:
Biblioteca Digital de Teses e Dissertações da USPUniversidade de São PauloUSP.
Esta pesquisa visa evidenciar as semelhanças existentes entre a proposta de Giambattista Vico sobre o começo das civilizações gentílicas e as argumentações rabínicas relativas ao episódio do Dilúvio Universal, narrado em Gênesis 6 e consid
Autor:
Niramol Savaraj, Angela Marini, Judith Hurley, Lynn G. Feun, Frederick L. Moffat, Amitabha Mazumder
Publikováno v:
Cancer investigation. 23(1)
Preclinical data suggest that one method of inducing autoimmunity to tumor is the administration and subsequent withdrawal of cyclosporine A following chemotherapy and that this effect may be enhanced with interferon and interleukin-2. Consequently,
Autor:
Garrett Lasalle, Howard J. Landy, Angela Marini, Isildinha M. Reis, Priscilla Potter, Arnold M. Markoe, Niramol Savaraj, Lynn G. Feun, Deborah Heros, Medhi Wangpaichitr
Publikováno v:
Journal of neuro-oncology. 67(1-2)
Patients with high grade glioma generally have poor prognoses. Addition of radiosensitizing agents might improve the response to irradiation. The chemotherapeutic agent estramustine sensitizes experimental gliomas to radiation. Gliomas express estram
Autor:
Eugene R. Schiff, Christopher B. O'Brien, Bach Ardalan, Niramol Savaraj, Lynn G. Feun, Angela Marini, Jeffers Lj, Miguel J. Rodriguez, Enrique Molina
Publikováno v:
Journal of cancer research and clinical oncology. 129(1)
To study the combination of 5FUDR, recombinant leukocyte interferon (IFN), and doxorubicin in patients with unresectable hepatocellular carcinoma. IFN was administered at a dose of 6 miu/m2 subcutaneously followed in 2 h by doxorubicin 20 mg/m2 intra